These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2869417)

  • 1. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
    Grigoriadis D; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):21-5. PubMed ID: 2869417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H; Wedel I
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M; Hidaka K; Nakamura Y
    Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-Dopamine binding sites differ in rat striatum and pituitary.
    Sokoloff P; Martres MP; Delandre M; Redouane K; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):221-7. PubMed ID: 6493362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB; Grigoriadis DE; Pri-Bar I; Buchman O; Seeman P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):333-43. PubMed ID: 2863760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
    Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
    Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
    Hamblin MW; Leff SE; Creese I
    Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide.
    Grigoriadis D; Seeman P
    J Neurochem; 1985 Jun; 44(6):1925-35. PubMed ID: 3157782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
    Richfield EK; Young AB; Penney JB
    Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates.
    Lazareno S
    J Recept Res; 1983; 3(1-2):163-75. PubMed ID: 6854546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
    Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P; Tallerico T; Ko F
    Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
    Cox RF; Waszczak BL
    Eur J Pharmacol; 1991 Jun; 199(1):103-6. PubMed ID: 1680055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ion modulates D2 receptor characteristics of dopamine agonist and antagonist binding sites in striatum and retina.
    Makman MH; Dvorkin B; Klein PN
    Proc Natl Acad Sci U S A; 1982 Jul; 79(13):4212-6. PubMed ID: 6213964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.